Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)
China · Delayed Price · Currency is CNY 2.840
-0.050 (-1.73%)
Aug 24, 2026, 3:00 PM CST
SHA:603363 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,756 | 12,000 | 9,224 | 5,283 | 11,228 | 8,692 | |
Market Cap Growth | -20.54% | 30.09% | 74.61% | -52.95% | 29.18% | 4.08% |
Enterprise Value | 10,067 | 14,360 | 16,765 | 14,485 | 20,590 | 18,173 |
Last Close Price | 2.84 | 4.61 | 3.54 | 6.07 | 12.89 | 12.70 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 154.59 | 15.92 | - | - | - |
Forward PE | - | 2.31 | 2.31 | 16.41 | 10.83 | 7.90 |
PS Ratio | 0.87 | 1.42 | 1.05 | 0.27 | 0.52 | 0.48 |
PB Ratio | 2.21 | 3.35 | 3.01 | -10.50 | 3.27 | 3.96 |
P/TBV Ratio | 3.17 | 4.85 | 4.88 | - | 7.93 | 24.68 |
P/FCF Ratio | 39.32 | - | - | 11.19 | - | - |
P/OCF Ratio | 20.34 | 78.46 | - | 5.37 | 16.92 | 16.58 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.13 | 1.69 | 1.91 | 0.74 | 0.95 | 1.01 |
EV/EBITDA Ratio | 42.06 | 48.08 | - | - | 88.48 | - |
EV/FCF Ratio | 51.03 | - | - | 30.67 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.67 | 0.65 | 0.95 | -16.41 | 2.70 | 4.27 |
Debt / EBITDA Ratio | 9.78 | 6.42 | - | - | 14.02 | - |
Debt / FCF Ratio | 11.86 | - | - | 17.49 | - | - |
Net Debt / Equity Ratio | 0.54 | 0.46 | 0.50 | -15.99 | 2.49 | 4.02 |
Net Debt / EBITDA Ratio | 10.85 | 5.46 | -6.16 | -4.53 | 36.75 | -15.34 |
Net Debt / FCF Ratio | 9.63 | -20.40 | -4.03 | 17.04 | -10.24 | -4.04 |
Asset Turnover | 0.99 | 0.93 | 0.76 | 1.21 | 1.21 | 1.24 |
Inventory Turnover | 8.45 | 8.98 | 7.80 | 9.00 | 7.13 | 8.43 |
Quick Ratio | 0.54 | 0.57 | 0.55 | 0.10 | 0.13 | 0.13 |
Current Ratio | 0.93 | 0.93 | 0.80 | 0.25 | 0.44 | 0.42 |
Return on Equity (ROE) | -5.05% | 2.69% | 4.93% | -257.10% | -43.56% | -60.72% |
Return on Assets (ROA) | -1.28% | -0.75% | -4.59% | -10.06% | -2.20% | -5.46% |
Return on Invested Capital (ROIC) | -3.49% | -1.90% | -18.50% | -36.48% | -5.46% | -13.29% |
Return on Capital Employed (ROCE) | -3.70% | -2.10% | -17.40% | -114.70% | -9.00% | -18.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.99% | 0.65% | 6.28% | -69.11% | -9.25% | -17.49% |
FCF Yield | 2.54% | -0.67% | -4.11% | 8.94% | -7.44% | -25.13% |
Payout Ratio | - | 108.87% | 13.19% | - | - | - |
Buyback Yield / Dilution | -68.03% | -199.23% | 0.29% | -11.91% | -19.30% | -3.15% |
Total Shareholder Return | -68.03% | -199.23% | 0.29% | -11.91% | -19.30% | -3.15% |